Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans

Archives of General Psychiatry

Volumn 66, Issue 10, 2009, Pages 1124-1134

  Love, Tiffany M ^a   Stohler, Christian S ^b   Zubieta, Jon Kar ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; MU OPIATE RECEPTOR; OPIATE;

ADULT; ARTICLE; BRAIN REGION; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; IMPULSIVENESS; MALE; MOTIVATION; NEUROTRANSMISSION; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PSYCHOPHYSICS; STRESS;

ADULT; BRAIN; CARBON RADIOISOTOPES; EMOTIONS; FENTANYL; HUMANS; INDIVIDUALITY; LIFE CHANGE EVENTS; MALE; PAIN; PAIN MEASUREMENT; PERSONALITY; PERSONALITY INVENTORY; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, OPIOID, MU; SYNAPTIC TRANSMISSION;

EID: 70349678800     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2009.134     Document Type: Article

References (89)

1. Whiteside SP, Lynam DR. The Five Factor Model and impulsivity: using a structural model of personality to understand impulsivity. Pers Individ Dif. 2001; 30(4):669-689. (Pubitemid 33380663)
2. Smith GT, Fischer S, Cyders MA, Annus AM, Spillane NS, McCarthy DM. On the validity and utility of discriminating among impulsivity-like traits. Assessment. 2007;14(2):155-170.
3. Fischer S, Anderson KG, Smith GT. Coping with distress by eating or drinking: role of trait urgency and expectancies. Psychol Addict Behav. 2004;18(3):269-274. (Pubitemid 39305171)
4. Madden GJ, Petry NM, Badger GJ, Bickel WK. Impulsive and self-control choices in opioid-dependent patients and non-drug-using control participants: drug and monetary rewards. Exp Clin Psychopharmacol. 1997;5(3):256-262.
5. Clark L, Robbins TW, Ersche KD, Sahakian BJ. Reflection impulsivity in current and former substance users. Biol Psychiatry. 2006;60(5):515-522. (Pubitemid 44292153)
6. Diergaarde L, Pattij T, Poortvliet I, Hogenboom F, de Vries W, Schoffelmeer AN, De Vries TJ. Impulsive choice and impulsive action predict vulnerability to distinct stages of nicotine seeking in rats. Biol Psychiatry. 2008;63(3):301-308.
7. Perry JL, Nelson SE, Carroll ME. Impulsive choice as a predictor of acquisition of IV cocaine self-administration and reinstatement of cocaine-seeking behavior in male and female rats. Exp Clin Psychopharmacol. 2008;16(2):165-177.
8. Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJ, Jensen PS, Cantwell DP. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet. 1998;351(9100):429-433.
9. American Psychiatric Association Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. 4th ed. Washington, DC: American Psychiatric Association; 2000.
10. Fahy T, Eisler I. Impulsivity and eating disorders. Br J Psychiatry. 1993;162:193-197.
11. Alessi SM, Petry NM. Pathological gambling severity is associated with impulsivity in a delay discounting procedure. Behav Processes. 2003;64(3):345-354.
12. Sinha R. How does stress increase risk of drug abuse and relapse? Psychopharmacology (Berl). 2001;158(4):343-359. (Pubitemid 33141310)
13. Krueger TH, Schedlowski M, Meyer G. Cortisol and heart rate measures during casino gambling in relation to impulsivity. Neuropsychobiology. 2005;52(4):206-211. (Pubitemid 41677020)
14. Mann JJ, Waternaux C, Haas GL, Malone KM. Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry. 1999;156(2):181-189. (Pubitemid 29077107)
15. Zouk H, Tousignant M, Seguin M, Lesage A, Turecki G. Characterization of impulsivity in suicide completers: clinical, behavioral and psychosocial dimensions. J Affect Disord. 2006;92(2-3):195-204.
16. Dalley JW, Fryer TD, Brichard L, Robinson ES, Theobald DE, Lääne K, Peña Y, Murphy ER, Shah Y, Probst K, Abakumova I, Aigbirhio FI, Richards HK, Hong Y, Baron JC, Everitt BJ, Robbins TW. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science. 2007;315(5816):1267-1270. (Pubitemid 46364262)
17. Rougé-Pont F, Deroche V, Le Moal M, Piazza PV. Individual differences in stress-induced dopamine release in the nucleus accumbens are influenced by corticosterone. Eur J Neurosci. 1998;10(12):3903-3907. (Pubitemid 29073945)
18. Rougé-Pont F, Piazza PV, Kharouby M, Le Moal M, Simon H. Higher and longer stress-induced increase in dopamine concentrations in the nucleus accumbens of animals predisposed to amphetamine self-administration: a microdialysis study. Brain Res. 1993;602(1):169-174. (Pubitemid 23045609)
19. Thierry AM, Tassin JP, Blanc G, Glowinski J. Selective activation of mesocortical DA system by stress. Nature. 1976;263(5574):242-244.
20. Kalivas PW, Churchill L, Romanides A. Involvement of the pallidal-thalamocortical circuit in adaptive behavior. Ann N Y Acad Sci. 1999;877:64-70. (Pubitemid 29351851)
21. Mogenson GJ, Yang CR. The contribution of basal forebrain to limbic-motor integration and the mediation of motivation to action. Adv Exp Med Biol. 1991;295:267-290.
22. Badiani A, Oates MM, Day HE, Watson SJ, Akil H, Robinson TE. Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: modulation by environmental novelty. J Neurosci. 1998;18(24):10579-10593. (Pubitemid 29016576)
23. Badiani A, Oates MM, Day HE, Watson SJ, Akil H, Robinson TE. Environmental modulation of amphetamine-induced c-fos expression in D1 versus D2 striatal neurons. Behav Brain Res. 1999;103(2):203-209. (Pubitemid 29418003)
24. Day HE, Badiani A, Uslaner JM, Oates MM, Vittoz NM, Robinson TE, Watson SJ Jr, Akil H. Environmental novelty differentially affects c-fos mRNA expression induced by amphetamine or cocaine in subregions of the bed nucleus of the stria terminalis and amygdala. J Neurosci. 2001;21(2):732-740. (Pubitemid 32107461)
25. Napier TC, Mitrovic I. Opioid modulation of ventral pallidal inputs. Ann N Y Acad Sci. 1999;877:176-201. (Pubitemid 29351858)
26. Uslaner J, Badiani A, Day HE, Watson SJ, Akil H, Robinson TE. Environmental context modulates the ability of cocaine and amphetamine to induce c-fos mRNA expression in the neocortex, caudate nucleus, and nucleus accumbens. Brain Res. 2001;920(1-2):106-116. (Pubitemid 33086784)
27. Peciña S, Berridge KC. Hedonic hot spot in nucleus accumbens shell: where do μ-opioids cause increased hedonic impact of sweetness? J Neurosci. 2005;25(50):11777-11786. (Pubitemid 43098470)
28. Smith KS, Berridge KC. Opioid limbic circuit for reward: interaction between hedonic hotspots of nucleus accumbens and ventral pallidum. J Neurosci. 2007;27(7):1594-1605.
29. Costa P, McRae R. Normal personality assessment in clinical practice: the NEO Personality Inventory. Psychol Assess. 1992;4(1):5-13.
30. Fisher S, Smith GT. Deliberation affects risk taking beyond sensation seeking. Pers Individ Dif. 2004;36(3):527-537.
31. Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, Meyer CR, Koeppe RA, Stohler CS. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science. 2001;293(5528):311-315. (Pubitemid 32694749)
32. Zubieta JK, Dannals RF, Frost JJ. Gender and age influences on human brain mu-opioid receptor binding measured by PET. Am J Psychiatry. 1999;156(6):842-848.
33. Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, Meyer CR, Koeppe RA, Stohler CS. μ-Opioid receptor - mediated antinociceptive responses differ in men and women. J Neurosci. 2002;22(12):5100-5107. (Pubitemid 37465623)
34. Smith YR, Stohler CS, Nichols TE, Bueller JA, Koeppe RA, Zubieta JK. Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women. J Neurosci. 2006;26(21):5777-5785.
35. Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, Goldman D. COMT val158met genotype affects μ-opioid neurotransmitter responses to a pain stressor. Science. 2003;299(5610):1240- 1243. (Pubitemid 36237467)
36. Stohler CS, Kowalski CJ. Spatial and temporal summation of sensory and affective dimensions of deep somatic pain. Pain. 1999;79(2-3):165-173.
37. Zhang X, Ashton-Miller JA, Stohler CS. A closed-loop system for maintaining constant experimental muscle pain in man. IEEE Trans Biomed Eng. 1993;40(4):344-352. (Pubitemid 24060702)
38. Melzack R, Torgerson W. On the language of pain. Anesthesiology. 1971;34(1):50-59.
39. Watson D, Clark L, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988;54(6):1063-1070.
40. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996;16(5):834-840. (Pubitemid 26292051)
41. Friston KJ, Worsley KJ, Frackowiak RS, Mazziotta JC, Evans AC. Assessing the significance of focal activations using their spatial extent. Hum Brain Mapp. 1994;1(3):210-220.
42. Dolcos F, LaBar KS, Cabeza R. Dissociable effects of arousal and valence on prefrontal activity indexing emotional evaluation and subsequent memory: an event-related fMRI study. Neuroimage. 2004;23(1):64-74. (Pubitemid 39119436)
43. 11C]-raclopride. Synapse. 2004;52(3):188-208.
44. 2 receptor in nonhuman primates. Synapse. 1992;10(3):177-184.
45. Winstanley CA, Theobald DE, Dalley JW, Robbins TW. Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders. Neuropsychopharmacology. 2005;30(4):669-682.
46. Kieres AK, Hausknecht KA, Farrar AM, Acheson A, de Wit H, Richards JB. Effects of morphine and naltrexone on impulsive decision making in rats. Psychopharmacology (Berl). 2004;173(1-2):167-174. (Pubitemid 38591162)
47. DixonMR,Marley J, Jacobs EA. Delay discounting by pathological gamblers. J Appl Behav Anal. 2003;36(4):449-458.
48. Giordano LA, Bickel WK, Loewenstein G, Jacobs EA, Marsch L, Badger GJ. Mild opioid deprivation increases the degree that opioid-dependent outpatients discount delayed heroin and money. Psychopharmacology (Berl). 2002;163(2):174-182. (Pubitemid 35013609)
49. Khachaturian H, Watson SJ. Some perspectives on monoamine-opioid peptide interaction in rat central nervous system. Brain Res Bull. 1982;9(1-6):441-462. (Pubitemid 13225287)
50. 2 receptor mRNA and opioid systems. Prog Clin Biol Res. 1990;328:227-230.
51. Vogt LJ, Sim-Selley LJ, Childers SR, Wiley RG, Vogt BA. Colocalization of μ -opioid receptors and activated G-proteins in rat cingulate cortex. J Pharmacol Exp Ther. 2001;299(3):840-848.
52. Spencer TJ, Biederman J, Wilens TE, Faraone SV. Overview and neurobiology of attention deficit/hyperactivity disorder. J Clin Psychiatry. 2002;63(suppl 12):3-9. (Pubitemid 36025581)
53. Volkow ND, Fowler JS, Wang GJ. The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology. 2004;47(suppl 1):3-13.
54. Reuter J, Raedler T, Rose M, Hand I, Gläscher J, Büchel C. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci. 2005;8(2):147-148. (Pubitemid 40194043)
55. Sesia T, Temel Y, Lim LW, Blokland A, Steinbusch HW, Visser-Vandewalle V. Deep brain stimulation of the nucleus accumbens core and shell: opposite effects on impulsive action [published online July 29, 2008]. Exp Neurol. 2008. doi:10.1016/j.expneurol.2008.07.015.
56. Cardinal RN, Pennicott DR, Sugathapala CL, Robbins TW, Everitt BJ. Impulsive choice induced in rats by lesions of the nucleus accumbens core. Science. 2001;292(5526):2499-2501.
57. Bechara A, Damasio AR, Damasio H, Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition. 1994;50(1-3):7-15.
58. Bechara A, Tranel D, Damasio H, Damasio AR. Failure to respond autonomically to anticipated future outcomes following damage to prefrontal cortex. Cereb Cortex. 1996;6(2):215-225. (Pubitemid 26117399)
59. Austin MC, Kalivas PW. Dopaminergic involvement in locomotion elicited from the ventral pallidum/substantia innominata. Brain Res. 1991;542(1):123-131.
60. Berridge KC. Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev. 1996;20(1):1-25.
61. Gong W, Neill D, Justice JB Jr. Conditioned place preference and locomotor activation produced by injection of psychostimulants into ventral pallidum. Brain Res. 1996;707(1):64-74. (Pubitemid 26046586)
62. Hiroi N, White NM. The ventral pallidum area is involved in the acquisition but not expression of the amphetamine conditioned place preference. Neurosci Lett. 1993;156(1-2):9-12. (Pubitemid 23214711)
63. Johnson PI, Stellar JR, Paul AD. Regional reward differences within the ventral pallidum are revealed by microinjections of a mu opiate receptor agonist. Neuropharmacology. 1993;32(12):1305-1314.
64. Napier TC. Dopamine receptors in the ventral pallidum regulate circling induced by opioids injected into the ventral pallidum. Neuropharmacology. 1992;31(11):1127-1136.
65. Tom SM, Fox CR, Trepel C, Poldrack RA. The neural basis of loss aversion in decision-making under risk. Science. 2007;315(5811):515-518. (Pubitemid 46175755)
66. Haber SN, Groenewegen HJ, Grove EA, Nauta WJ. Efferent connections of the ventral pallidum: evidence of a dual striato pallidofugal pathway. J Comp Neurol. 1985;235(3):322-335.
67. Kelley AE, Baldo BA, Pratt WE, Will MJ. Corticostriatal-hypothalamic circuitry and food motivation: integration of energy, action and reward. Physiol Behav. 2005;86(5):773-795. (Pubitemid 41728993)
68. Kabbaj M, Norton CS, Kollack-Walker S, Watson SJ, Robinson TE, Akil H. Social defeat alters the acquisition of cocaine self-administration in rats: role of individual differences in cocaine-taking behavior. Psychopharmacology (Berl). 2001;158(4):382-387. (Pubitemid 33141314)
69. Marinelli M, White FJ. Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons. J Neurosci. 2000;20(23):8876-8885.
70. Piazza PV, Deminiere JM, Le Moal M, Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science. 1989;245(4925):1511-1513. (Pubitemid 19243245)
71. Piazza PV, Deroche-Gamonent V, Rouge-Pont F, Le Moal M. Vertical shifts in self-administration dose-response functions predict a drug-vulnerable phenotype predisposed to addiction. J Neurosci. 2000;20(11):4226-4232. (Pubitemid 30365693)
72. Dellu F, Piazza PV, Mayo W, Le Moal M, Simon H. Novelty-seeking in rats: biobehavioral characteristics and possible relationship with the sensation-seeking trait in man. Neuropsychobiology. 1996;34(3):136-145. (Pubitemid 26355758)
73. Deroche V, Piazza PV, Casolini P, Maccari S, Le Moal M, Simon H. Stress-induced sensitization to amphetamine and morphine psychomotor effects depend on stress-induced corticosterone secretion. Brain Res. 1992;598(1-2):343-348. (Pubitemid 23013082)
74. Deroche V, Piazza PV, Le Moal M, Simon H. Individual differences in the psychomotor effects of morphine are predicted by reactivity to novelty and influenced by corticosterone secretion. Brain Res. 1993;623(2):341-344. (Pubitemid 23275424)
75. Deroche V, Piazza PV, Le Moal M, Simon H. Social isolation - induced enhancement of the psychomotor effects of morphine depends on corticosterone secretion. Brain Res. 1994;640(1-2):136-139. (Pubitemid 24086541)
76. Rougé-Pont F, Marinelli M, Le Moal M, Simon H, Piazza PV. Stress-induced sensitization and glucocorticoids, II: sensitization of the increase in extracellular dopamine induced by cocaine depends on stress-induced corticosterone secretion. J Neurosci. 1995;15(11):7189-7195. (Pubitemid 3010056)
77. Lucas LR, Angulo JA, Le Moal M, McEwen BS, Piazza PV. Neurochemical characterization of individual vulnerability to addictive drugs in rats. Eur J Neurosci. 1998;10(10):3153-3163.
78. Bry BH. Reducing the incidence of adolescent problems through preventive intervention: one- and five-year follow-up. Am J Community Psychol. 1982;10(3):265-276.
79. Bush G, Vogt BA, Holmes J, Dale AM, Greve D, Jenike MA, Rosen BR. Dorsal anterior cingulate cortex: a role in reward-based decision making. Proc Natl Acad Sci U S A. 2002;99(1):523-528. (Pubitemid 34060394)
80. Oswald LM, Wong DF, Zhou Y, Kumar A, Brasic J, Alexander M, Ye W, Kuwabara H, Hilton J, Wand GS. Impulsivity and chronic stress are associated with amphetamine-induced striatal dopamine release. Neuroimage. 2007;36(1):153-166. (Pubitemid 46617942)
81. Laakso A, Wallius E, Kajander J, Bergman J, Eskola O, Solin O, Ilonen T, Salokangas RK, Syvälahti E, Hietala J. Personality traits and striatal dopamine synthesis capacity in healthy subjects. Am J Psychiatry. 2003;160(5):904-910. (Pubitemid 41079575)
82. Unterwald EM, Horne-King J, Kreek MJ. Chronic cocaine alters brain mu opioid receptors. Brain Res. 1992;584(1-2):314-318.
83. Unterwald EM, Tempel A, Koob GF, Zukin RS. Characterization of opioid receptors in rat nucleus accumbens following mesolimbic dopaminergic lesions. Brain Res. 1989;505(1):111-118. (Pubitemid 20011115)
84. Unterwald EM, Rubenfeld JM, Kreek MJ. Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. Neuroreport. 1994;5(13):1613-1616. (Pubitemid 24265254)
85. 2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum. Neuroscience. 1993;54(3):669-680.
86. Steiner H, Gerfen CR. Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp Brain Res. 1998;123(1-2):60-76. (Pubitemid 28495297)
87. George SR, Kertesz M. Met-enkephalin concentrations in striatum respond reciprocally to alterations in dopamine neurotransmission. Peptides. 1987;8(3):487-492. (Pubitemid 17119184)
88. Zubieta JK, Gorelick DA, Stauffer R, Ravert HT, Dannals RF, Frost JJ. Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. Nat Med. 1996;2(11):1225-1229. (Pubitemid 26375406)
89. Kagan J, Reznick JS, Snidman N. Biological bases of childhood shyness. Science. 1988;240(4849):167-171.